NA Selank Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 2 to 4 weeks on, 2 to 4 weeks off; some protocols extend to 6 weeks on with a proportional break; total programs commonly run 8 to 16 weeks across multiple cycles
• Frequency: Once daily subcutaneous; intranasal protocols use two to three times daily; 5 days on / 2 days off is an alternative
• Common delivery routes: Subcutaneous injection; intranasal spray
• Key timing notes: Morning dosing preferred for nootropic benefit; avoid dosing after late afternoon as mild stimulating effects can affect sleep in sensitive individuals; rotate injection sites on each administration

Who This Protocol Is For

NA Selank draws two broad groups: people managing anxiety who want something that works without sedation or dependence risk, and people chasing cognitive enhancement, clearer thinking, and steadier focus. In Russian clinical practice, where Selank has over-the-counter status in intranasal form, those two goals have coexisted since the compound was first studied. In the North American research community, the same populations drive most of the protocol data.

If your primary goal is anxiety management, Selank's profile is distinctly different from what most people expect from an anxiolytic. It does not sedate. It does not cause the cognitive blunting or amnesia associated with benzodiazepines. Users commonly describe a calm that sits alongside mental clarity rather than blurring it. That profile makes it appealing for people who want to stay functional while reducing the baseline noise of chronic anxiety or generalized anxiety disorder.

If your goal is cognitive performance, Selank occupies a different position than stimulant-class nootropics. The effects are closer to a quieting of the background, which makes concentration easier, rather than a sharp caffeinated push. Many users run it alongside Semax, where Selank handles the anxiety and Semax handles focus and mental drive. That combination is one of the more discussed pairings in the peptide community and is useful context even if you are running Selank on its own.

Experience level shapes the protocol in one specific way: newer users are consistently advised to start toward the lower end of the range and give the compound a full week or two before drawing conclusions. Selank's effects build over consistent use. The instinct to push the dose up quickly after a quiet first day or two is one of the most commonly reported protocol errors.

Delivery route preference matters as well. Subcutaneous injection produces a more stable, consistent experience across a cycle. The intranasal route provides faster acute onset and removes needle use from the equation entirely, but the protocol structure differs meaningfully between the two in frequency and cycle length. Both are covered in this guide.

How Is a NA Selank Cycle Structured?

A NA Selank cycle is built on a simple on-and-off rhythm. You run the compound consistently for a defined period, take a break roughly as long as the cycle itself, and repeat if your program calls for more than one cycle. The underlying reason for cycling is mechanistic: the GABAergic pathways (the brain's calming signaling system) that Selank works through are susceptible to receptor desensitization (where the receptors become less responsive to the compound over time) with prolonged continuous use. A scheduled break resets that sensitivity and keeps the compound working as expected in subsequent cycles.

The subcutaneous protocol typically runs two to four weeks on, followed by a two to four week break. Some users and practitioners extend the on-cycle to six weeks, particularly for sustained cognitive benefit or managing a chronic anxiety baseline. When the on-cycle stretches, the off-cycle tends to stretch proportionally. Total programs across multiple cycles commonly span eight to sixteen weeks.

The intranasal protocol follows a shorter rhythm. Russian clinical data typically uses fourteen to twenty-one days on, followed by a one to three week break. The shorter cycle reflects both the higher daily frequency intranasal protocols require and the different pharmacokinetic picture of nasal absorption compared to subcutaneous delivery.

What a NA Selank cycle does not have is a loading phase that uses a different amount to front-load the compound. The dose stays consistent from day one through the end of the cycle. What changes is not the amount administered but the gradual accumulation of effect, which builds as consistent use continues. The full detail on how that plays out across the cycle is in the Loading and Maintenance Phases section below.

How Your Dose Is Determined

What moves a NA Selank dose:

• Your goal: The two primary goals sit in different places on the range. Anxiety-focused protocols trend toward the lower end, where the calming effect is established without the mild stimulating quality that can emerge toward the higher end. Cognitive enhancement goals, particularly when Selank is paired with a focus-enhancing compound, tend to land toward the middle and higher end. Ongoing maintenance for someone who has run multiple cycles may settle below where they started, while an acute period of elevated anxiety or demand may trend higher within the range.

• Experience level: Newer users consistently start at the lower end, giving the body a week or two to establish baseline response before any adjustment. More experienced users who have run prior cycles and know how they respond personally may start closer to the middle. The compound does not benefit from aggressive early escalation; community data on this point is consistent.

• Delivery route: Subcutaneous and intranasal protocols use different dose structures. Subcutaneous delivery concentrates the daily amount into a single morning administration and produces a steadier, more predictable experience. Intranasal protocols split the daily amount into two or three administrations to account for the absorption differences and shorter action window of nasal delivery. The total daily amounts between the two routes are not equivalent; the intranasal route typically requires a higher total daily amount to achieve comparable effects.

• Individual response: Two people running the same goal and the same route can land at meaningfully different places on the range. Some users find the lower end more than sufficient and report that going higher adds mild stimulation without adding anxiolytic benefit. Others need to step up before the cognitive clarity they were chasing comes through clearly. Individual response is a genuine variable.

There is no single dose that fits everyone running NA Selank, which is the specific problem the MyPeptidePal Protocol Creator is built to solve.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your goal type, your preferred delivery route, and your experience level with the compound and builds your NA Selank protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take NA Selank?

The standard subcutaneous protocol uses once daily dosing. That frequency fits the compound well. Selank has a relatively short half-life, and its effects build through consistent accumulation rather than through sustained peak plasma levels held across the day. Once daily delivery establishes consistent exposure without requiring multiple administrations.

Morning dosing is the most consistently recommended timing across practitioner and community reports. Two reasons drive this. First, the nootropic component is most useful when it is online for the working portion of the day. Second, Selank carries a mild stimulating quality for some users that can affect sleep onset if the compound is still active later in the evening. Avoiding administration after the mid-to-late afternoon is a standard precaution in protocols, not a hard rule for everyone, but a sensible default.

A common alternative to strict daily dosing is five days on, two days off, typically Monday through Friday with the weekend off. This pattern is well-established in the community as a practical middle ground: it maintains consistent weekday exposure while building in a two-day break that some users find helps sustain response over a longer program.

The intranasal protocol uses two to three administrations daily rather than one, split across morning and midday to account for the shorter absorption window of nasal delivery. Community reports consistently show the intranasal route providing faster acute onset, often within twenty to thirty minutes, but a less sustained daily effect than subcutaneous injection. Users who prioritize a stable all-day baseline tend to favor the injectable route for this reason.

For both routes, timing consistency matters more than the specific clock time. Selank's effects build through reliable, predictable dosing patterns. Frequently changing the time of day, skipping doses, or running an irregular schedule undermines the gradual accumulation the compound depends on to work well.

Loading and Maintenance Phases

NA Selank does not use a loading phase in the traditional sense. There is no front-loaded period where the dose runs higher before stepping down to a maintenance level. The dose is consistent from the first day of the cycle through the last, and the arc of effect reflects the compound's gradual buildup rather than any change in what is being administered.

What the cycle does have is a natural early phase and a settled phase that emerge from how the compound accumulates over time. In the first one to two weeks, many users report that effects are present but variable. A calming quality typically appears early, sometimes from the first administration, but the full cognitive and anxiolytic effect is not reliably stable yet. A plateau or inconsistent period around days five to nine is frequently noted in community logs, where effects some days feel stronger and others feel flat. This is a normal part of how Selank establishes its baseline. Holding the dose steady through this period rather than adjusting it is the right call.

By weeks two through four on a subcutaneous protocol, effects for most users who have found their appropriate level tend to become more stable and predictable. This is the settled phase. The dose has not changed. What has changed is the compound's established presence and the body's calibration to it.

The off-cycle break is a genuine part of the protocol structure, and the full rationale for it is covered in the Off-Cycle Considerations section below.

For intranasal protocols using the shorter fourteen to twenty-one day cycle, the same structural logic applies: consistent dose throughout, an early variable phase, a settled phase, and an off-cycle reset. The shorter rhythm simply moves through that pattern more quickly.

Off-Cycle Considerations

Cycling off NA Selank is mechanistically necessary, not optional. Selank works partly through the brain's calming signaling system, and continuous stimulation of those pathways over extended periods leads to the receptors becoming less responsive to the compound over time. The break allows that reduced sensitivity to reverse before the next cycle begins.

The standard break length mirrors the on-cycle: a four-week on period is followed by a roughly four-week break. Shorter cycles, particularly the two-week intranasal protocol common in Russian clinical practice, use a one to two week break. The principle is that the break should be long enough for sensitivity to meaningfully reset.

Selank has no withdrawal syndrome. Stopping at the end of a cycle does not produce rebound anxiety, dependence, or physical symptoms. Users and practitioners consistently note this as one of the compound's more relevant characteristics compared to other compounds that act on the same calming pathways. The off-cycle period is physiologically uneventful for most people; effects simply fade as the compound clears.

Some users manage longer programs by adopting pulsing schedules rather than strict on-and-off blocks. The five days on, two days off weekly schedule described in the timing section is one version. A three weeks on, one week off rotation serves a similar function, trading the clean break of a matched off-cycle for a shorter, more frequent reset. Which approach fits depends on the total program length, the goal, and individual response across multiple cycles.

One practical note: a single missed dose does not require compensation. Taking two doses in a row provides no benefit and raises the chance of unwanted effects. A missed day means taking the next scheduled dose at the normal time and continuing from there.

What to Expect Week by Week

• Week 1 to 2: Many users notice something from the first administration, most commonly described as a subtle calming or a mild warmth in outlook, typically appearing within fifteen to twenty minutes. By days three to five, the anxiolytic quality tends to be more reliably present for anxiety-focused users. A plateau or inconsistent period around days five to nine is frequently reported in community logs, where effects feel stronger on some days and flat on others. This is a normal part of how Selank builds its baseline, not a signal that something is wrong with the dose.

• Week 2 to 3: For most users dosing consistently at an appropriate level, effects begin to stabilize. The variation that characterized the early phase gives way to a more predictable baseline. Anxiety reduction tends to stabilize first; cognitive clarity follows. Users running the five-day-on, two-day-off schedule report that the weekend break does not significantly interrupt this stabilization.

• Week 3 to 4 (and beyond for extended cycles): The settled phase. Community reports describe this period as where the compound's effects are most consistent. Anxiety-focused users commonly report their most stable results here. Cognitive enhancement users describe the mental clarity and reduced background noise as most reliable in this window.

• Beyond 4 weeks: For users extending to six weeks, most reports describe effects holding well through week five and into week six before response begins to flatten. The flattening is the signal that the off-cycle period is due.

For someone running NA Selank primarily for anxiety management and staying consistent with morning dosing through the full cycle, the realistic arc looks like this: a variable but promising first week, a noticeably more stable second week, and a third and fourth week where the compound is working at its most consistent. Users who have stayed the course through the early variability commonly describe the latter half of their first cycle as a meaningful shift in daily baseline: anxiety less intrusive, cognitive load lighter, and sleep quality sometimes improved as a secondary effect. That progression reflects consistent, appropriately-dosed use and is commonly reported, not guaranteed.

Common Protocol Mistakes

Escalating the dose during the early variability phase. The days five to nine period where effects plateau or become inconsistent is widely noted and is a normal part of how Selank builds. It is not a signal that the dose is too low. Users who push the dose up during this window commonly find that effects do not improve proportionally and that the risk of overstimulation rises. Holding the dose steady and giving the compound two full weeks to establish its baseline is the better approach.

Dosing in the late afternoon or evening. Selank carries a mild stimulating quality for some users. Administration after the mid-to-late afternoon is a consistently noted setup for sleep disruption. Morning dosing is the standard recommendation across both practitioner and community sources, and it is one of the simplest adjustments a protocol can make.

Skipping the off-cycle break. Users who run continuous cycles without taking a break frequently report diminished response in subsequent runs. The break is where receptor sensitivity resets. Skipping it borrows against the effectiveness of the next cycle rather than extending the current one.

Inconsistent timing and compensating for missed doses. Selank's effects build through reliable, predictable exposure. Frequently changing the administration time or doubling up after a missed dose undermines the accumulation pattern. A missed dose means taking the next scheduled dose normally, not compensating with a larger amount.

Injection site issues. For subcutaneous users, rotating the site on every administration prevents scar tissue buildup and maintains absorption consistency. Injecting into the same spot repeatedly concentrates tissue damage and reduces absorption over time. Allowing the alcohol prep wipe to fully dry before injecting prevents stinging and avoids introducing alcohol into the site.

Storage and handling after reconstitution. Selank degrades at room temperature. Reconstituted solution should be refrigerated immediately and kept consistently cold. The vial should be swirled gently rather than shaken, and solution should be clear before use. Cloudy or off-color solution should be discarded.

NA Selank is not FDA-approved for human therapeutic use in the United States, and as of April 2026 it was withdrawn from the FDA's Category 2 compounded drugs list, which affects how domestically compounded forms are regulated. Athletes in tested sports should confirm current status with their relevant anti-doping authority before use.

Frequently Asked Questions

How long is a typical NA Selank cycle?

Most subcutaneous protocols run two to four weeks on, followed by a two to four week break. Some users extend the on-cycle to six weeks for cognitive enhancement goals, with a proportional break to follow. Total programs across multiple cycles commonly run eight to sixteen weeks, and your specific cycle length is shaped by your goal and individual response.

How often do you take NA Selank?

The subcutaneous protocol uses once daily dosing, most commonly in the morning. Intranasal protocols use two to three administrations per day to account for the shorter absorption window of nasal delivery. A five days on, two days off weekly schedule is a well-established alternative for users managing longer programs.

Does NA Selank need a loading phase?

No. NA Selank does not use a loading phase with a higher starting dose. The dose is consistent from the first day of the cycle through the last. What changes over the cycle is the gradual accumulation of effect, which typically stabilizes and becomes more predictable by the end of the second week.

Do you need to cycle off NA Selank?

Yes, and the reason is mechanistic. Selank works partly through the brain's calming signaling system, and continuous use without a break leads to the receptors becoming less responsive over time, which reduces the compound's effectiveness. A break roughly equal in length to the on-cycle allows sensitivity to reset. Selank has no withdrawal syndrome, so the off-cycle period is physiologically straightforward for most users.

Can NA Selank be taken intranasally instead of by injection?

Yes. Intranasal delivery is the standard clinical form in Russia, where Selank has over-the-counter status. The intranasal protocol differs structurally from the subcutaneous one: it uses a shorter cycle, a higher daily administration frequency, and a different total daily amount. Subcutaneous injection is generally reported to produce a more stable, sustained daily effect, while intranasal delivery provides faster acute onset and removes needle use from the equation.

What is the most commonly reported early experience on NA Selank?

A subtle calming or mild shift in outlook is the most frequently reported first-dose experience, typically appearing within fifteen to twenty minutes. By days three to five of consistent dosing, the anxiolytic effect tends to be more reliably present. A plateau or variable period around days five to nine is commonly noted and is a normal part of how the compound builds its effect, not a signal that the dose needs adjustment.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for NA Selank in one place.